Last reviewed · How we verify
NCT06158997
Safety and Effectiveness of EyePeace on Signs and Symptoms of Dry Eye Disease
NA trial testing EyePeace in Evaporative Dry Eye in 60 participants. Status unknown.
1 February 2024
Quick facts
| Lead sponsor | He Eye Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 3 December 2023 |
| Primary completion | 1 February 2024 |
| Estimated completion | 1 April 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- EyePeace
- Heated Eye Mask
Conditions studied
- Evaporative Dry Eye — all drugs for Evaporative Dry Eye →
Sponsor
He Eye Hospital
Who can join
Adults 18 to 99, any sex, with Evaporative Dry Eye. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study, the EyePeace an eye massager will be compared with a standard-of-care warm compress treatment with evaporative dry eye disease. The objective is to asses the safety and effectiveness EyePeace eye massager is in relieving the signs and symptoms of evaporative dry eye disease.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Immediate sequential changes in the tear film lipid layer following eyelid massage in dry eye syndrome: A comparative control study.
Chen J, Yu S, Qin G, Moutari S, et al · · 2024 · cited 3× · PMID 39286233 · DOI 10.1016/j.heliyon.2024.e36590 -
Immediate sequential changes in the tear film lipid layer following eyelid massage in dry eye syndrome: A comparative control study
Chen J, Yu S, Qin G, Moutari S, et al · · 2024
Verify or expand the search:
- PubMed search for NCT06158997
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Evaporative Dry Eye
Currently open trials in the same condition.
- NCT06913387 — Comparative Efficacy of Lipid Based Artificial Tears vs Aqueous Based Artificial Tears in Managing EDE · NA · active not recruiting
Other He Eye Hospital trials
Trials by the same sponsor.
- NCT07097922 — Compare the Clinical Efficacy of 3% Diquafosol and 0.1% Hyaluronic Acid in Patients With Dry Eye After LASIK · NA · not yet recruiting
- NCT06852105 — Compare the Clinical Efficacy of 3% Diquafosol and 0.1% Hyaluronic Acid in Patients with Dry Eye After Trans-PRK · NA · not yet recruiting
- NCT06714994 — Effect of Spectacle Distribution to Myopic Secondary School Students in Rural Communities of Liaoning Province on Commun · NA · not yet recruiting
- NCT06656403 — Effect of Artificial Tears on Ocular Biometry Parameters · NA · not yet recruiting
- NCT06537349 — Effects of 3% Diquafosol on Tear Film and Vision-related Quality of Life in Orthokeratology Lens Related Dry Eye · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06158997 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by He Eye Hospital
- Last refreshed: 6 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06158997.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing